From Information to Innovation

The member companies of the IGES Group contribute to designing infrastructures: for healthcare, transport, housing and education. For more than 40 years we have delivered research and consulting services – analyses, expert opinions, studies, concepts and strategies – in Europe.

6,000

Projects

200

Employees

14

Companies

6

Countries

Data

the basis for all our work

with in-house

  • Biometrics & Statistics
  • Software development
  • Data Science & Big Data
  • IT & Data Security
Pandemie Monitor

BIO International 2024

IGES Institut

Expert discussion with IGES: Focus on transatlantic cooperation in the biotech sector

The world's largest biotech congress of its kind, the BIO International Convention, has a strong European focus this year. With the participation of the IGES Group, it brings together major European pharmaceutical and biotech stakeholders to discuss the latest changes in EU legislation and their consequences for the transatlantic pharmaceutical market. » Details

Bio Europe 2023

IGES Institut

EU HTA harmonisation under time pressure: discussion at the biotech congress "BIO Europe 2023

The time pressure due to EU HTA harmonisation is growing. In less than 15 months, the first medicinal products will have to undergo a central clinical evaluation procedure. IGES looks ahead to the start at BIO Europe 2023. » Details

IGES France Pharma Consulting

IGES Institut

IGES sets up a new subsidiary in France – IGES France Pharma Consulting

The IGES Group continues to grow and has set up IGES France Pharma Consulting to proposes strategic and health economics consulting services for the developers and manufacturers of medicinal products seeking to place products on the French and European markets. » Details

Synergus RWE

IGES Institut

IGES acquires majority stake in Synergus RWE – a European Medtech market access specialist

IGES Group continues to expand its consulting services for developers and manufacturers of medical devices. To this end, the IGES Institute has acquired a majority stake in Synergus RWE. » Details

Evaluation of long-term care advice

IGES Institut

Evaluation of long-term care advice

The care counselling services provided by the long-term care insurance funds have been further expanded and the majority of people in need of care, including their relatives, are satisfied with them. However, there is still room for improvement. » Details

IGES

Companies of the IGES Group

Business Area

Public Infrastructures in Germany, Austria, Switzerland

  • Health
  • Transport
  • Education
  • Housing

Business Area

LifeScience - Access to Europe

  • Medtech
  • Pharmaceuticals
  • Digital Health